GO
Loading...

Enter multiple symbols separated by commas

Biotech and Pharmaceuticals Medicine

More

  • July 20- Bristol-Myers Squibb Co said a late-stage trial of its drug, Opdivo, was stopped early after the immunotherapy was found to be effective in patients with the most common form of kidney cancer. The drug competes with Merck& Co's Keytruda. AstraZeneca Plc, Pfizer Inc and other drugmakers are also developing PD-1 inhibitors, or similar drugs known as PD-L1...

  • Bristol's Opdivo found effective in kidney cancer Monday, 20 Jul 2015 | 8:30 AM ET

    July 20- Bristol-Myers Squibb Co said a late-stage trial testing Opdivo was stopped early after it was found beneficial in patients with the most common form of kidney cancer. An independent data committee recommended the trial be stopped, after it concluded that patients receiving Opdivo showed superior overall survival, compared to those who did not.

  • July 20- Less than 24 hours after a deadly infection of bird flu was confirmed at a turkey farm north of Des Moines, Iowa, Bud Wood packed about 3,500 rare baby chicks into boxes and put them in the back of a truck. He plans to keep the chickens in Texas through next spring while he monitors the virus in the Iowa epicenter. Bird flu has killed more than 48 million chickens...

  • Telehealth: Visit your doctor through an app Tuesday, 14 Jul 2015 | 11:56 AM ET
    Telehealth: Visit your doctor through an app

    Oscar Salazar, Pager co-founder and fmr. Uber CTO, discusses Telehealth and the latest statements made by Hillary Clinton on the economy and jobs.

  • July 13- The U.S. Food and Drug Administration approved AstraZeneca Plc's drug, Iressa, as a first-line treatment for a common form of lung cancer. The FDA said on Tuesday the approval was based on results from a trial of 106 patients with previously untreated non-small cell lung cancer. The National Cancer Institute estimates more than 158,000 will die from the...

  • July 13- The U.S. Food and Drug Administration has approved AstraZeneca Plc's drug, Iressa, as a first-line treatment for a common form of lung cancer. The drug was previously approved for use in non-small cell lung cancer patients only after they did not respond to chemotherapy. The FDA said on Tuesday the approval was based on results from a trial of 106 patients...

  • Is the search for immortality a rich man's game? Saturday, 11 Jul 2015 | 9:00 AM ET
    Ben Kingsley and Ryan Reynolds in a scene from the movie “Self/less”

    Technology and medicine are probing the boundaries of mortality. So can only the rich afford to drink from the fountain of youth?

  • 1 pill too many? Painkillers under scrutiny Friday, 10 Jul 2015 | 2:18 PM ET
    Ibuprofen

    The FDA has new warnings for taking painkillers like ibuprofen. Here are some of your questions answered by NBC News.

  • Weighing the risks of ibuprofen Friday, 10 Jul 2015 | 1:56 PM ET
    Weighing the risks of ibuprofen

    Discussing safer alternatives to ibuprofen after the FDA warnings, with Dr. Devi Nampiaparampil, NYU School of Medicine. "All of the alternatives have risks," she explains.

  • July 10- The U.S. food and Drug Administration said it was strengthening an existing warning label that non-aspirin, non-steroidal anti-inflammatory drugs increase the chance of a heart attack or stroke. NSAIDs are used to treat pain and fever from medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, and some of the better-known...

  • Before you pop that ibuprofen, read new warnings Thursday, 9 Jul 2015 | 7:35 PM ET
    Ibuprofen tablets

    The FDA is strengthening its warnings about painkillers like ibuprofen, saying they do raise the risk of heart attack or stroke.

  • Study links Prozac, Paxil use with birth defects Thursday, 9 Jul 2015 | 5:18 PM ET

    July 9- A sweeping government study of thousands of women has found links between the older antidepressants Prozac and Paxil and birth defects, but has cleared other popular treatments in the class, including Celexa, Lexapro and Pfizer's Zoloft, which is the subject of a major lawsuit over birth defect claims. Earlier studies had raised questions about...

  • WASHINGTON, July 9- An advisory panel to the U.S. Food and Drug Administration effectively supported approval of Eli Lilly& Co's experimental lung cancer drug necitumumab on Thursday but recommended measures be taken to mitigate the drug's risks. The panel did not officially vote but an informal poll taken by the FDA indicated most members believe the...

  • AstraZeneca divests gastrointestinal drug for $215 mln Thursday, 9 Jul 2015 | 3:07 AM ET

    LONDON, July 9- AstraZeneca struck a further "externalisation" deal on Thursday to help fill its short-term revenue gap by divesting its gastrointestinal drug Entocort for $215 million. The transaction is expected to complete in the second half of 2015 and AstraZeneca said it would reinforce its strategic focus on selected therapy areas, such as cancer,...

  • Gene therapy for deafness moves a few steps closer Wednesday, 8 Jul 2015 | 2:00 PM ET

    *Novartis tests gene therapy in adults with damaged hearing. Separately, a clinical trial backed by Novartis is under way to help a different group of people who have lost their hearing through damage or disease. "We are somewhat late in the auditory field but I think we are getting there now," said Tobias Moser of the University Medical Center Gottingen, Germany, who...

  • PuraPharm CEO: Not worried about market rout Tuesday, 7 Jul 2015 | 7:49 PM ET
    PuraPharm CEO: Not worried about market rout

    CNBC's Susan Li asks Abraham Chan, founder, chairman, CEO and executive director of PuraPharm, whether he is worried about how the recent market rout may affect the company's listing in Hong Kong.

  • The USDA is aiming to assign one person to communicate with each infected farm during the entire time the facility is affected by the deadly virus, John Clifford, the chief U.S. veterinary officer, said at a U.S. Senate Agriculture Committee hearing on Tuesday. Currently, a USDA representative deals with an infected farm for a period of about three to four weeks as...

  • *Novartis may offer pay-for-performance deals. July 7- Novartis AG on Tuesday won U.S. approval for its keenly awaited new heart failure drug Entresto earlier than expected, boosting hopes for a medicine tipped by analysts to reap billions of dollars in annual sales. Novartis is looking to Entresto to help revive its fortunes in heart medicine as the blood...

  • July 7- Novartis AG on Tuesday won U.S. approval for its keenly awaited new heart failure drug Entresto earlier than expected, boosting hopes for a medicine tipped by analysts to reap billions of dollars in annual sales. Novartis is looking to Entresto to help revive its fortunes as the blood pressure pill Diovan- a major source of the company's profits in the past-...

  • Wild birds that spread the virus will very likely carry it when they begin migrating south in the fall, John Clifford, the USDA's chief veterinary officer, said in remarks prepared for a U.S. Senate Agriculture Committee hearing on Tuesday. Clifford testified before the Senate committee after U.S. lawmakers from Iowa criticized the USDA for taking too long to...